|
KIAA1267 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.045360E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.950400E-01 |
| Normal-vs-Stage2 |
1.441770E-01 |
| Normal-vs-Stage3 |
1.662230E-02 |
| Normal-vs-Stage4 |
8.820000E-03 |
| Stage1-vs-Stage2 |
2.799400E-01 |
| Stage1-vs-Stage3 |
2.867800E-02 |
| Stage1-vs-Stage4 |
2.127700E-02 |
| Stage2-vs-Stage3 |
6.230200E-01 |
| Stage2-vs-Stage4 |
4.402600E-01 |
| Stage3-vs-Stage4 |
6.900800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.377600E-02 |
| Normal-vs-AfricanAmerican |
4.009200E-01 |
| Normal-vs-Asian |
9.659800E-03 |
| Caucasian-vs-AfricanAmerican |
6.085600E-01 |
| Caucasian-vs-Asian |
2.097500E-03 |
| AfricanAmerican-vs-Asian |
2.148100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.160000E-02 |
| Normal-vs-Female |
5.310800E-01 |
| Male-vs-Female |
3.542300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.053800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.920000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.862300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.032340E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.087000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.580800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.254600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.169850E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.846100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.146200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.155600E-03 |
| Normal-vs-Grade 2 |
5.192000E-01 |
| Normal-vs-Grade 3 |
2.372100E-02 |
| Normal-vs-Grade 4 |
1.976300E-03 |
| Grade 1-vs-Grade 2 |
3.956900E-03 |
| Grade 1-vs-Grade 3 |
9.81239999999772E-05 |
| Grade 1-vs-Grade 4 |
4.65910000002623E-06 |
| Grade 2-vs-Grade 3 |
3.654100E-02 |
| Grade 2-vs-Grade 4 |
6.637600E-03 |
| Grade 3-vs-Grade 4 |
1.915190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.475800E-01 |
| Normal-vs-ccB subtype |
2.245700E-02 |
| ccA subtype-vs-ccB subtype |
7.994400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.310000E-01 |
| Normal-vs-N1 |
4.596800E-01 |
| N0-vs-N1 |
9.615600E-01 |
|
|
